608 related articles for article (PubMed ID: 23939434)
1. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
Han J; Hiebert LM
Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
[TBL] [Abstract][Full Text] [Related]
2. Heparanase upregulation in high glucose-treated endothelial cells is prevented by insulin and heparin.
Han J; Woytowich AE; Mandal AK; Hiebert LM
Exp Biol Med (Maywood); 2007 Jul; 232(7):927-34. PubMed ID: 17609509
[TBL] [Abstract][Full Text] [Related]
3. Changes in cultured endothelial cell glycosaminoglycans under hyperglycemic conditions and the effect of insulin and heparin.
Han J; Zhang F; Xie J; Linhardt RJ; Hiebert LM
Cardiovasc Diabetol; 2009 Aug; 8():46. PubMed ID: 19695080
[TBL] [Abstract][Full Text] [Related]
4. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
[TBL] [Abstract][Full Text] [Related]
5. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
[TBL] [Abstract][Full Text] [Related]
6. Endothelial cell injury by high glucose and heparanase is prevented by insulin, heparin and basic fibroblast growth factor.
Han J; Mandal AK; Hiebert LM
Cardiovasc Diabetol; 2005 Aug; 4():12. PubMed ID: 16086844
[TBL] [Abstract][Full Text] [Related]
7. Acute UV irradiation increases heparan sulfate proteoglycan levels in human skin.
Jung JY; Oh JH; Kim YK; Shin MH; Lee D; Chung JH
J Korean Med Sci; 2012 Mar; 27(3):300-6. PubMed ID: 22379342
[TBL] [Abstract][Full Text] [Related]
8. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
9. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
Roskams T; Rosenbaum J; De Vos R; David G; Desmet V
Hepatology; 1996 Sep; 24(3):524-32. PubMed ID: 8781318
[TBL] [Abstract][Full Text] [Related]
10. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
Kosir MA; Quinn CC; Wang W; Tromp G
J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
[TBL] [Abstract][Full Text] [Related]
11. Expression of heparan sulfate proteoglycans in murine models of experimental colitis.
Patterson AM; Delday MI; van Kuppevelt TH; Loh G; Blaut M; Haller D; Grant G; Kelly D
Inflamm Bowel Dis; 2012 Jun; 18(6):1112-26. PubMed ID: 21987406
[TBL] [Abstract][Full Text] [Related]
12. Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis.
Patel VN; Knox SM; Likar KM; Lathrop CA; Hossain R; Eftekhari S; Whitelock JM; Elkin M; Vlodavsky I; Hoffman MP
Development; 2007 Dec; 134(23):4177-86. PubMed ID: 17959718
[TBL] [Abstract][Full Text] [Related]
13. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
Yeaman C; Rapraeger AC
J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
Fisher MC; Li Y; Seghatoleslami MR; Dealy CN; Kosher RA
Matrix Biol; 2006 Jan; 25(1):27-39. PubMed ID: 16226436
[TBL] [Abstract][Full Text] [Related]
15. Glycosaminoglycans, hyperglycemia, and disease.
Hiebert LM; Han J; Mandal AK
Antioxid Redox Signal; 2014 Sep; 21(7):1032-43. PubMed ID: 24224492
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of ryudocan and syndecan heparan sulfate proteoglycans, core proteins, and cDNAs from a rat endothelial cell line.
Shworak NW; Kojima T; Rosenberg RD
Haemostasis; 1993 Mar; 23 Suppl 1():161-76. PubMed ID: 8495865
[TBL] [Abstract][Full Text] [Related]
17. Heparin releasable and nonreleasable forms of heparan sulfate proteoglycan are found on the surfaces of cultured porcine aortic endothelial cells.
Lowe-Krentz LJ; Thompson K; Patton WA
Mol Cell Biochem; 1992 Jan; 109(1):51-60. PubMed ID: 1614420
[TBL] [Abstract][Full Text] [Related]
18. Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway.
Yu S; Lv H; Zhang H; Jiang Y; Hong Y; Xia R; Zhang Q; Ju W; Jiang L; Ou G; Zhang J; Wang S; Zhang J
Biochem Biophys Res Commun; 2017 Apr; 485(2):432-439. PubMed ID: 28209511
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulfate chains with antimitogenic properties arise from mesangial cell-surface proteoglycans.
Wang A; Miralem T; Templeton DM
Metabolism; 1999 Oct; 48(10):1220-9. PubMed ID: 10535382
[TBL] [Abstract][Full Text] [Related]
20. Expression of proteoglycan core proteins in human bone marrow stroma.
Schofield KP; Gallagher JT; David G
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):663-8. PubMed ID: 10527946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]